Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

1. Management of Acute Myocardial Infarction During the COVID?19 Pandemic Full Text available with Trip Pro

Management of Acute Myocardial Infarction During the COVID?19 Pandemic Management of acute myocardial infarction during the COVID‐19 pandemic - Mahmud - - Catheterization and Cardiovascular Interventions - Wiley Online Library COVID-19 campus closures: see options for to subscribed content. By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Core Curriculum Free Access Management of acute myocardial infarction during (...) is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID‐19 pandemic. It is critical to inform the public that we can minimize exposure to the coronavirus so they continue to call the emergency medical system (EMS) for acute ischemic heart disease symptoms and therefore get the appropriate level of cardiac care that their presentation warrants; target the use of primary percutaneous coronary intervention (PCI) or fibrinolysis

2020 Society for Cardiovascular Angiography and Interventions

2. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial Full Text available with Trip Pro

Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show (...) . doi: 10.1016/j.jacc.2020.01.050. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial , , , , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators Yoga-CaRe Trial Investigators : , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations 1 Centre for Chronic Disease Control, New Delhi, India; Public Health Foundation of India, New Delhi, India; London School of Hygiene

2020 EvidenceUpdates

3. Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial

Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial Exercise Intervention Improves Quality of Life in Older Adults After Myocardial Infarction: Randomised Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) Create file Cancel Actions Cite Share Permalink Copy Page navigation Heart Actions . 2020 Mar 6;heartjnl-2019-316349. doi: 10.1136/heartjnl-2019-316349. Online ahead of print. Exercise Intervention Improves Quality of Life in Older Adults After Myocardial Infarction: Randomised Clinical Trial , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy cmpglc@unife.it. 2 Cardiology Unit, Azienda Ospedaliera

2020 EvidenceUpdates

4. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study

Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- To 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed (...) any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Ann Emerg Med Actions . 2020 Feb 8;S0196-0644(19)31440-4. doi: 10.1016/j.annemergmed.2019.12.008. Online ahead of print. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- To 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study , , , , , , , , Affiliations

2020 EvidenceUpdates

5. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome

Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features (...) management software Create file Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions . 2020 Mar 17;75(10):1095-1106. doi: 10.1016/j.jacc.2019.12.067. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome , , , , , , , , Affiliations Expand Affiliations 1 TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

2020 EvidenceUpdates

6. Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes (Abstract)

Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes Patients with diabetes mellitus (DM) have elevated levels of high-sensitivity cardiac troponin (hs-cTn). We investigated the diagnostic performance of the European Society of Cardiology (ESC) algorithms to rule out or rule in acute myocardial infarction (AMI) without ST-elevation in patients with DM.We prospectively enrolled 3,681 patients

2020 EvidenceUpdates

7. Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared with Females without Breast Cancer

Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared with Females without Breast Cancer Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared With Females Without Breast Cancer - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Am J Med Actions 2019 Nov 9 [Online ahead of print] Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared With Females Without Breast Cancer , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Cardiology. 2

2020 EvidenceUpdates

8. Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49)

Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy (...) , Emory University School of Medicine, Atlanta, Georgia. 9 Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. PMID: 31870492 DOI: Item in Clipboard Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) C Michael Gibson et al. Am J Cardiol . 2019 Show details Am J Cardiol Actions Authors , , , , , , , , , , , , , Affiliations 1 Cardiovascular Division

2020 EvidenceUpdates

9. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial

Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features (...) a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions , 74 (22), 2713-2723 2019 Dec 3 Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Centre

2020 EvidenceUpdates

10. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Full Text available with Trip Pro

Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Long-term Ticagrelor for Secondary Prevention in Patients With Prior Myocardial Infarction and No History of Coronary Stenting: Insights From PEGASUS-TIMI 54 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go (...) your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Eur Heart J Actions 2019 Dec 7 [Online ahead of print] Long-term Ticagrelor for Secondary Prevention in Patients With Prior Myocardial Infarction and No History of Coronary Stenting: Insights From PEGASUS-TIMI 54

2020 EvidenceUpdates

11. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library of Medicine National Center (...) to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions , 74 (21), 2572-2584 2019 Nov 26 Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

2020 EvidenceUpdates

12. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features (...) Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Interventional Cardiology Department, Cardiovascular Institute, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain (M.S., S.B.). 2 Hospital Universitario de La Princesa, Madrid, Spain (F.A., J.C.). 3 Hospital Universitario de Bellvitge, IDIBELL, Barcelona, Spain (A.C., J.A.G.H.). 4 Hospital San Pedro de Alcántara

2020 EvidenceUpdates

13. ACC, SCAI, ACEP Release Consensus Statement on Management of acute myocardial infarction Patients During COVID-19

ACC, SCAI, ACEP Release Consensus Statement on Management of acute myocardial infarction Patients During COVID-19 Management of Acute Myocardial Infarction During the COVID-19 Pandemic | JACC: Journal of the American College of Cardiology Advertisement User menu Source Search for this keyword Search Source Search for this keyword Search Journal of the American College of Cardiology DOI: 10.1016/j.jacc.2020.04.039 Just Accepted Management of Acute Myocardial Infarction During the COVID-19 (...) -19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy

2020 American College of Cardiology

14. Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease Full Text available with Trip Pro

Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease Background and Purpose- More intensive secondary prevention with newer drugs may be cost-effective in patients with coronary artery disease (CAD). Whether some subgroups of patients who had a transient ischemic attack (TIA) or ischemic stroke, but no prior CAD are at similar high risk of myocardial infarction as those with prior CAD remains unclear. We (...) determined whether the Essen score identified a subset of TIA/stroke patients without known prior CAD who, nevertheless, had a high risk of myocardial infarction on current secondary prevention management. Methods- In a population-based cohort (Oxford Vascular Study) of consecutive TIA or ischemic stroke patients recruited from 2002 to 2014, 10-year actuarial risks of myocardial infarction and of recurrent ischemic stroke were determined by face-to-face follow-up in patients with and without prior CAD

2019 EvidenceUpdates

15. Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction (Abstract)

Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction Patients with non-ST-segment elevation myocardial infarction and elevated high-sensitivity cardiac troponin levels often routinely undergo invasive coronary angiography (ICA), but many do not have obstructive coronary artery disease.This study investigated whether cardiovascular magnetic resonance imaging (CMR) or computed tomographic angiography (CTA) may serve as a safe (...) gatekeeper for ICA.This randomized controlled trial (NCT01559467) in 207 patients (age 64 years; 62% male patients) with acute chest pain, elevated high-sensitivity cardiac troponin T levels (>14 ng/l), and inconclusive electrocardiogram compared a CMR- or CTA-first strategy with a control strategy of routine clinical care. Follow-up ICA was recommended when initial CMR or CTA suggested myocardial ischemia, infarction, or obstructive coronary artery disease (≥70% stenosis). Primary efficacy and secondary

2019 EvidenceUpdates

16. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial) Full Text available with Trip Pro

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial) Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (From the GLOBAL LEADERS Trial) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions , 124 (12), 1833-1840 2019 Dec 15 Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (From the GLOBAL LEADERS Trial) , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand

2019 EvidenceUpdates

17. Complete Revascularization with Multivessel PCI for Myocardial Infarction. Full Text available with Trip Pro

Complete Revascularization with Multivessel PCI for Myocardial Infarction. In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction. Whether PCI of nonculprit lesions further reduces the risk of such events is unclear.We randomly assigned patients with STEMI and multivessel coronary artery disease who had undergone successful culprit-lesion PCI (...) to a strategy of either complete revascularization with PCI of angiographically significant nonculprit lesions or no further revascularization. Randomization was stratified according to the intended timing of nonculprit-lesion PCI (either during or after the index hospitalization). The first coprimary outcome was the composite of cardiovascular death or myocardial infarction; the second coprimary outcome was the composite of cardiovascular death, myocardial infarction, or ischemia-driven

2019 NEJM Controlled trial quality: predicted high

18. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. Full Text available with Trip Pro

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. To estimate the risk of acute myocardial infarction (AMI) or stroke in adults with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH).Matched cohort study.Population based, electronic primary healthcare databases before 31 December 2015 from four European countries: Italy (n=1 542 672), Netherlands (n=2

2019 BMJ

19. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Full Text available with Trip Pro

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Newer-generation drug-eluting stents that combine ultrathin strut metallic platforms with biodegradable polymers might facilitate vascular healing and improve clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary (...) intervention (PCI) compared with contemporary thin strut second-generation drug-eluting stents. We did a randomised clinical trial to investigate the safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stents versus thin strut durable polymer everolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI.The BIOSTEMI trial was an investigator-initiated, multicentre, prospective, single-blind, randomised superiority trial

2019 Lancet

20. Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines

Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines | CADTH.ca Find the information you need Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative Safety, and Guidelines Thrombolytics for Acute Myocardial Infarction in a Prehospital Setting: A Review of Comparative (...) Safety, and Guidelines Last updated: July 9, 2019 Project Number: RC1144-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the comparative safety of thrombolytic administration performed in a prehospital versus hospital setting for treatment of acute myocardial infarction? What is the comparative safety of thrombolytic administration performed in a prehospital setting compared with no or significantly delayed thrombolytic

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review